MOREPENLABMorepen Laboratories Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹58.23
▼ 1.14%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)3,428.00
P/E36.16
P/B2.82
PEG—
ROE %7.86
ROCE %6.10
Debt / Equity0.17
EPS1.73
Revenue Growth %4.00
Profit Growth %-18.90
Dividend Yield %0.33
Promoter Holding %42.69
FII Holding %1.36
DII Holding %—
Beta0.70
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹58.23 | ₹55.36 | ₹64.67 | 2.24 |
HOLDConviction 59%
The picture
- • Debt/Equity: 0.17
- • Valuation vs sector: P/E 36.2 vs sector 38.6
- • RSI: 55
- • Price vs EMA21: above
- • Price vs SMA50: above
- • 1-month return: +17.6%
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Debt/Equity: 0.17
- • Valuation vs sector: P/E 36.2 vs sector 38.6
- • RSI: 55
- • Price vs EMA21: above
Bear case
- • Revenue growth: 4.0% YoY
- • Profit growth: -18.9% YoY
- • MACD: bearish
- • Volume: 0.3x 20-day average
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 4.0% YoY
- • Profit growth: -18.9% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹58.23
Stop Loss
₹51.05
risk 12.3%
Target 1 (1.5R)
₹69.00
+18.5%
Target 2 (3R)
₹79.77
+37.0%
Support (20d)
₹50.00
Resistance (52w)
₹64.84
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹7.18/share
ATR (volatility)
₹2.87
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹2.87). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
35
Technical
66
Momentum
90
Risk (safety)
51